ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH04 | G | Quetiapine fumarate - 50mg | 7855 | 186119/13 | REZAL XR | 50mg | 30 | Tablet, extended release | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 533,505 L.L | 23.08 | A1 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH04 | G | Quetiapine fumarate - 50mg | 11079 | 164520/1 | QUETIAPINE BIOGARAN L.P. | 50mg | 30 | Tablet, prolonged release | Oral | Commercial and Trading Ressources SAL (CTR) | Pharmathen International SA | Greece | 1,010,570 L.L | 23.08 | A2 | Laboratoires Biogaran | France | 2/5/2024 | 0 |